title: Immunotherapy of malignant melanoma.
abstract: The growth of melanoma in humans depends not only on the malignant potential of the tumor but also on the patient's immune response to the melanoma. As a result, a variety of strategies have evolved to treat melanoma by stimulating antitumor immune responses to melanoma. This article reviews the different approaches being taken and the results obtained to date.
authors.affiliation: Kaplan Cancer Center, New York University School of Medicine, New York.
authors.forename: R
authors.initials: R
authors.lastname: Oratz
authors.forename: J C
authors.initials: JC
authors.lastname: Bystryn
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D016219:Immunotherapy, Adoptive; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*; D014611:Vaccination
chemical_list: D000911:Antibodies, Monoclonal; D007376:Interleukin-2; D007372:Interferons